Recent Advances in Small Molecular Fluorescence Probes for Fatty Liver Diseases

Fatty liver diseases are a spectrum of disorders consisting the benign fatty liver, which could eventually lead to cirrhosis or even hepatocellular cancer (HCC) without timely treatment. Therefore, early diagnosis is crucial for diseases. Liver biopsy regarded as gold standard in However, it not recommended routine use due its invasiveness and complicated operation. Thus, urgent diagnose with non-invasive precise methods. In this regard, fluorescence imaging technology has attracted intensive attention become robust method visualization, series fluorescent probes being intensively designed track biomarkers liver. brief review, small molecular employed summarized, mainly focusing on last four years. Moreover, current opportunities challenges development will be highlighted.